Literature DB >> 11536043

P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

L Faridoni-Laurens1, J Bosq, F Janot, M Vayssade, M L Le Bihan, M Kaghad, D Caput, J Bénard, J C Ahomadegbe.   

Abstract

P73, a p53-homologue gene, has been studied for its possible role in head and neck squamous epithelium (HNSE) differentiation and carcinogenesis. P73 RNA and protein were analysed in 50 biopsies, including well- and moderately-differentiated carcinomas, and 21 matched normal adjacent tissues. P73 immunohistochemical analyses revealed intense p73 nuclear staining in basal and parabasal cells of normal squamous epithelium, in contrast with complete absence of staining in the more superficial cell layers. Moderately-differentiated carcinomas demonstrated homogeneous and diffuse staining in all tumour cells, while only basal cells were stained in well-differentiated carcinomas as in normal tissue. No correlation was observed between p73 and p53 protein expression. Immunostaining for p63, another p53-related protein previously described as being involved in HNSE morphogenesis and overexpressed in head and neck squamous cell carcinomas (HNSCC), was found to be similar to p73 labelling in carcinomas, but spread to the more differentiated layers in normal epithelium. Biallelic expression of p73 was found in tumours as well as in matched normal tissues. Comparison of p73 transcript levels between tumours and normal tissues showed decreased mRNA expression in 5/17 (30%) tumours independently of the differentiation status. Mutation and loss of heterozygosity analyses of the p73 gene revealed wild type status and no deletion. Our results strongly suggest that: (i) p73 is associated with homeostasis and control of differentiation of head and neck squamous epithelium probably in concert with p53 and p63; (ii) down-regulation of p73 expression could participate in HNSE carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536043     DOI: 10.1038/sj.onc.1204687

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Clinical implications of the deregulated TP73 isoforms expression in cancer.

Authors:  N Rodríguez; A Peláez; R Barderas; G Domínguez
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

2.  p73alpha is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes.

Authors:  A Oniscu; N Sphyris; R G Morris; S Bader; D J Harrison
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

3.  Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.

Authors:  Yuk-Kwan Chen; Shue-Sang Huse; Li-Min Lin
Journal:  Int J Exp Pathol       Date:  2004-04       Impact factor: 1.925

4.  p53 Family: Role of Protein Isoforms in Human Cancer.

Authors:  Jinxiong Wei; Elena Zaika; Alexander Zaika
Journal:  J Nucleic Acids       Date:  2011-10-09

5.  Argyrophilic nuclear organizer region and p73 expression in head and neck squamous cell carcinomas: Teammates or adversaries?

Authors:  Sunil Pazhayanur Venkateswaran; Leviana Ercylina Nathan; Vimi Sunil Mutalik; Noor Hasni Shamsuddin
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

6.  Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia.

Authors:  Sunit B Patel; Bhari S Manjunatha; Vandana Shah; Nishit Soni; Rakesh Sutariya
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-10-26

7.  TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.

Authors:  Hui Ye; Xia Guo
Journal:  Biosci Rep       Date:  2019-08-05       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.